Clinical Trial Update: Extended Ambulatory Monitoring Improves Risk Stratification in Hypertrophic Cardiomyopathy

View source ↗

Summary

Clinical trial update indicates that extended ambulatory monitoring improves risk stratification in hypertrophic cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Snippet

Sponsor: Atlantic Health System | Conditions: Hypertrophic Cardiomyopathy | Status: UNKNOWN